Mesothelioma Study Using Fitbit to Monitor Patient Recovery
Millions of Americans use Fitbit devices to track their daily activities, exercise and sleep patterns. But a student intern at the Pacific Heart, Lung &Blood Institute (PHLBI) in California is using the popular fitness tracker for a different purpose — as a tool to measure postsurgery recovery for mesothelioma patients. Blair Kimble, a third-year undergraduate student at UCLA, is leading the latest clinical research project for the Pacific Mesothelioma Center (PCM), a division of PHLBI. Kimble is working closely with mesothelioma surgeon Dr. Robert Cameron, the scientific advisor at PHLBI. The study investigates some of first quantitative measures of postoperative mesothelioma patient recovery using Fitbit wristbands to collect data about a patient’s walking habits, heart rate and sleep patterns before and after surgery. “Using their data from before surgery as a baseline for their activity, we are then able to track how quickly they return to that normal baseline after surgery,” Kimble wrote in a PHLBI blog post explaining the study. The overall goal of the project is to use the Fitbit devices to motivate patients to return to presurgery physical activity levels, according to Dr. Raymond Wong, PHLBI lead researcher and head of the intern program. “This could ultimately result in shorter hospital stays on average and the use of Fitbit trackers as standard postsurgery monitoring,” Wong told Asbestos.com. Patient Recovery Is Under I...
Publication date: 15 February 2021Source: Journal of Hazardous Materials, Volume 404, Part BAuthor(s): Yanhua Liu, Yang Li, Shanshan Dong, Lu Han, Ruixin Guo, Yourong Fu, Shenghu Zhang, Jianqiu Chen
We describe the most highly recommended generic and disease-specific PRO tools in SCD and discuss the challenges of incorporating them in clinical practice. EXPERT OPINION: PRO measures are essential to incorporate into SCD clinical trials either as primary or secondary outcomes. The use of PRO measures in SCD facilitates a patient-centered approach, which is likely to lead to improved outcomes. Significant challenges remain in adapting PRO tools to routine clinical use and in developing countries. PMID: 33034214 [PubMed - as supplied by publisher]
Authors: Musio F Abstract INTRODUCTION: Anemia has and will continue to be a central theme in medicine particularly as clinicians are treating a burgeoning population of complex multi-organ system processes. As a result of multiple randomized controlled trials (RCTs), meta-analyses, and societal recommendations overly restrictive paradigms and under-administration of erythropoiesis stimulating agents (ESAs) have likely been followed by clinicians among all specialties. AREAS COVERED: A review of anemia in the context of chronic kidney disease, hematologic malignancies and cancer is presented with focus on the e...
Publication date: January 2021Source: Urology Case Reports, Volume 34Author(s): Nina Al-Saadi, Safa Al-Musawi, Yousuf Khan, Daben Dawam
Publication date: Available online 10 October 2020Source: European Journal of Surgical OncologyAuthor(s): Tetsutaro Miyoshi, Satoshi Yamaguchi, Hiroshi Fujimoto, Shigeru Yoshioka, Masayuki Shiobara, Kazuo Wakatsuki, Kosuke Suda, Kotaro Miyazawa, Toshiaki Aida, Yoshihiro Watanabe, Masayuki Ohtsuka
Currently in fellowship doing bread/butter procedures (MBB, epidurals, PNB, few SCS/PNS trials, etc.) and just interviewed at a private practice spot where they do a lot of procedures that I will have not done any training in prior to graduating (e.g. IT pump, SI fusion, Vertiflex, Kypho, MILD, Discectomy, lots of SCS/PNS trials etc) and significant amount of "OR pain procedures" at a very busy practice seeing 30-40 pts/day - how many of you are commonly performing these procedures and are... private practice concern
Authors: Matti B, Zargar-Shoshtari K Abstract Prostate cancer represents a significant health burden worldwide. The cancer incidence had substantially increased since the introduction of prostate specific antigen (PSA) in cancer screening. This had led to considerable debates among health professionals and epidemiologists, since PSA as a screening tool seemed to be far from perfect. In New Zealand, the controversy was quite prominent in the last three decades, with some advocating the benefits of screening, while others concerned regarding the risk of harms. With the absence of an organised screening programme and ...
CONCLUSION: This study found that childhood cancer survivors in New Zealand had a high prevalence of developmental dental abnormalities and it identified potential risk factors related to their cancer treatment. Inequitable access to oral rehabilitation for this patient group argues for a mechanism for consistent improved access to publicly funded dental care across district health boards in New Zealand. PMID: 33032302 [PubMed - in process]
Authors: Zarrabi A, Mark S PMID: 33032299 [PubMed - in process]
Authors: Zhao N, Xiang Q, Liu Z, Zhao X, Cui Y Abstract INTRODUCTION: There remains an unmet need for better anticoagulants. The phase I clinical trial is of great significance in the development of anticoagulants, and the design is special. This system review aims to provide insights for the design of future phase I clinical trials of anticoagulants. AREAS COVERED: We searched the database PubMed and ClinicalTrail.gov website, to collate the phase I clinical trial of anticoagulants in healthy people. The study protocol, inclusion exclusion criteria, safety and pharmacodynamic indexes were reviewed. EXPERT ...
More News: Academia | Asbestosis | Biomedical Science | Bleeding | Blogging | Cancer | Cancer & Oncology | Cardiology | Chemotherapy | Clinical Trials | Colleges | Cryotherapy | Environmental Health | Graduation | Grants | Heart | Hospitals | Immunotherapy | Internships | Laboratory Medicine | Mesothelioma | Pain | Science | Sleep Disorders | Sleep Medicine | Sports Medicine | Students | Study | Training | Universities | Universities & Medical Training | Women